333 related articles for article (PubMed ID: 8621941)
1. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C
J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941
[TBL] [Abstract][Full Text] [Related]
2. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
3. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
4. Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity.
Jabado N; Le Deist F; Fisher A; Hivroz C
Eur J Immunol; 1994 Nov; 24(11):2646-52. PubMed ID: 7957556
[TBL] [Abstract][Full Text] [Related]
5. Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors.
Rieckmann P; Poli G; Fox CH; Kehrl JH; Fauci AS
J Immunol; 1991 Nov; 147(9):2922-7. PubMed ID: 1918999
[TBL] [Abstract][Full Text] [Related]
6. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?
Herbeuval JP; Shearer GM
AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946
[TBL] [Abstract][Full Text] [Related]
7. Induction of IFN-alpha by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication.
Francis ML; Meltzer MS
J Immunol; 1993 Aug; 151(4):2208-16. PubMed ID: 8345204
[TBL] [Abstract][Full Text] [Related]
8. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL
Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040
[TBL] [Abstract][Full Text] [Related]
9. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
Ahmad A; Ladha A; Cohen EA; Menezes J
Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
[TBL] [Abstract][Full Text] [Related]
10. TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.
Thibault S; Imbeault M; Tardif MR; Tremblay MJ
Virology; 2009 Jun; 389(1-2):20-5. PubMed ID: 19447460
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
12. The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients.
Gerencer M; Burek V; Crowe BA; Barrett NP; Dorner F
Microb Pathog; 1998 Nov; 25(5):253-66. PubMed ID: 9878454
[TBL] [Abstract][Full Text] [Related]
13. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
[TBL] [Abstract][Full Text] [Related]
14. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
Capobianchi MR
J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 reactivation in resting peripheral blood mononuclear cells of infected adults upon in vitro CD4 cross-linking by ligands of the CDR2-loop in extracellular domain 1.
Briant L; Reynes J; Coudronnière N; Benezech JP; Devaux C
J Acquir Immune Defic Syndr; 1999 May; 21(1):9-19. PubMed ID: 10235509
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone inhibits CD4 T cell deletion mediated by macrophages from human immunodeficiency virus-infected persons.
Orlikowsky TW; Wang ZQ; Dudhane A; Dannecker GE; Niethammer D; Wormser GP; Hoffmann MK; Horowitz HW
J Infect Dis; 2001 Nov; 184(10):1328-30. PubMed ID: 11679924
[TBL] [Abstract][Full Text] [Related]
19. Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells.
Bachrach E; Dreja H; Lin YL; Mettling C; Pinet V; Corbeau P; Piechaczyk M
Virology; 2005 Feb; 332(1):418-29. PubMed ID: 15661172
[TBL] [Abstract][Full Text] [Related]
20. Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells.
Beirnaert E; De Zutter S; Janssens W; van der Groen G
Virology; 2001 Mar; 281(2):305-14. PubMed ID: 11277702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]